Bioavailability of a novel anti-influenza agent, onradivir granules, in healthy Chinese adults: a first-in-human study.

Yi X, Liu Y, Wang X, Peng Y, Fu J, Li Y, Li H, Zhang H

Open source

DOI
10.3389/fphar.2026.1905152
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1905152,
  title = {Bioavailability of a novel anti-influenza agent, onradivir granules, in healthy Chinese adults: a first-in-human study.},
  author = {Yi X and Liu Y and Wang X and Peng Y and Fu J and Li Y and Li H and Zhang H},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1905152},
  url = {https://doi.org/10.3389/fphar.2026.1905152}
}

RIS

TY  - JOUR
TI  - Bioavailability of a novel anti-influenza agent, onradivir granules, in healthy Chinese adults: a first-in-human study.
AU  - Yi X
AU  - Liu Y
AU  - Wang X
AU  - Peng Y
AU  - Fu J
AU  - Li Y
AU  - Li H
AU  - Zhang H
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1905152
UR  - https://doi.org/10.3389/fphar.2026.1905152
ER  - 

APA

X, Y., Y, L., X, W., Y, P., J, F., Y, L., H, L., & H, Z. (2026). Bioavailability of a novel anti-influenza agent, onradivir granules, in healthy Chinese adults: a first-in-human study.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1905152

Source records